Brett R Hagen insider trades: Kalaris Therapeutics (KLRS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brett reports to the SEC
Open-market buys and sales
38 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | KLRS | ↓ Sell | 1,915 | $6.72 | $13K | Direct | Mar 23, 2026 (3d) |
| Mar 26, 2025 | KLRS | ↓ Sell | 907 | $8.97 | $8K | Direct | Mar 27, 2025 (1d) |
| Feb 21, 2025 | ALVR | ↓ Sell | 96 | $10.08 | $967 | Direct | Feb 24, 2025 (3d) |
| Jan 23, 2025 | ALVR | ↓ Sell | 36 | $9.51 | $342 | Direct | Jan 27, 2025 (4d) |
| Jan 10, 2025 | ALVR | ↓ Sell | 332 | $0.44 | $146 | Direct | Jan 13, 2025 (3d) |
| Nov 19, 2024 | ALVR | ↓ Sell | 554 | $0.55 | $304 | Direct | Nov 20, 2024 (1d) |
| Nov 5, 2024 | ALVR | ↓ Sell | 1,655 | $0.86 | $1K | Direct | Nov 6, 2024 (1d) |
| Oct 22, 2024 | ALVR | ↓ Sell | 965 | $0.77 | $746 | Direct | Oct 23, 2024 (1d) |
| Oct 3, 2024 | ALVR | ↓ Sell | 301 | $0.81 | $245 | Direct | Oct 4, 2024 (1d) |
| Aug 19, 2024 | ALVR | ↓ Sell | 544 | $0.76 | $413 | Direct | Aug 20, 2024 (1d) |
| Aug 5, 2024 | ALVR | ↓ Sell | 1,692 | $0.73 | $1K | Direct | Aug 7, 2024 (2d) |
| Jul 22, 2024 | ALVR | ↓ Sell | 960 | $0.74 | $715 | Direct | Jul 23, 2024 (1d) |
| Jul 2, 2024 | ALVR | ↓ Sell | 304 | $0.72 | $219 | Direct | Jul 3, 2024 (1d) |
| May 17, 2024 | ALVR | ↓ Sell | 541 | $0.75 | $405 | Direct | May 21, 2024 (4d) |
| May 3, 2024 | ALVR | ↓ Sell | 1,597 | $0.80 | $1K | Direct | May 7, 2024 (4d) |
| Apr 22, 2024 | ALVR | ↓ Sell | 953 | $0.75 | $715 | Direct | Apr 23, 2024 (1d) |
| Apr 2, 2024 | ALVR | ↓ Sell | 281 | $0.77 | $217 | Direct | Apr 4, 2024 (2d) |
| Feb 20, 2024 | ALVR | ↓ Sell | 494 | $0.70 | $343 | Direct | Feb 22, 2024 (2d) |
| Feb 8, 2024 | ALVR | ↓ Sell | 11,150 | $0.67 | $7K | Direct | Feb 9, 2024 (1d) |
| Feb 5, 2024 | ALVR | ↓ Sell | 5,792 | $0.67 | $4K | Direct | Feb 6, 2024 (1d) |
| Jan 23, 2024 | ALVR | ↓ Sell | 901 | $0.67 | $604 | Direct | Jan 25, 2024 (2d) |
| Jan 4, 2024 | ALVR | ↓ Sell | 310 | $0.64 | $198 | Direct | Jan 8, 2024 (4d) |
| Dec 27, 2023 | ALVR | ↓ Sell | 28,335 | $0.74 | $21K | Direct | Jan 2, 2024 (6d) |
| Nov 17, 2023 | ALVR | ↓ Sell | 403 | $1.63 | $657 | Direct | Nov 21, 2023 (4d) |
| Oct 20, 2023 | ALVR | ↓ Sell | 715 | $1.56 | $1K | Direct | Oct 23, 2023 (3d) |
| Oct 3, 2023 | ALVR | ↓ Sell | 222 | $1.98 | $439 | Direct | Oct 5, 2023 (2d) |
| Aug 17, 2023 | ALVR | ↓ Sell | 1,653 | $2.50 | $4K | Direct | Aug 21, 2023 (4d) |
| Jul 20, 2023 | ALVR | ↓ Sell | 684 | $3.45 | $2K | Direct | Jul 21, 2023 (1d) |
| Jun 9, 2023 | ALVR | ↓ Sell | 5,045 | $5.64 | $28K | Direct | Jun 13, 2023 (4d) |
| Apr 20, 2023 | ALVR | ↓ Sell | 697 | $3.67 | $3K | Direct | Apr 21, 2023 (1d) |
| Jan 20, 2023 | ALVR | ↓ Sell | 1,895 | $5.09 | $10K | Direct | Jan 23, 2023 (3d) |
| Nov 11, 2022 | ALVR | ↓ Sell | 24,000 | $8.13 | $195K | Direct | Nov 14, 2022 (3d) |
| Oct 24, 2022 | ALVR | ↓ Sell | 13,679 | $8.43 | $115K | Direct | Oct 24, 2022 (0d) |
| Apr 20, 2022 | ALVR | ↓ Sell | 276 | $6.68 | $2K | Direct | Apr 22, 2022 (2d) |
| Jan 20, 2022 | ALVR | ↓ Sell | 1,563 | $8.75 | $14K | Direct | Jan 24, 2022 (4d) |
| Feb 22, 2021 | ALVR | ↓ Sell | 800 | $43.14 | $35K | Direct | Feb 23, 2021 (1d) |
| Feb 18, 2021 | ALVR | ↓ Sell | 741 | $40.11 | $30K | Direct | Feb 19, 2021 (1d) |
| Feb 17, 2021 | ALVR | ↓ Sell | 5,370 | $41.26 | $222K | Direct | Feb 18, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KLRS insiders
Open-market trades in the last 12 months
About Brett R Hagen's insider trades
Brett R Hagen is Chief Accounting Officer at Kalaris Therapeutics (KLRS). Since Feb 17, 2021, Brett has reported no open-market purchases and 38 sales worth $725K on SEC Form 4. In the last 12 months: 1 sale ($13K).
Their filings also include grants and awards (10 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KLRS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.